SUPN Earnings

Quarterly EPS
$0.70
Q3 2024
$0.28
Q4 2024
$-0.21
Q1 2025
$0.40
Q2 2025
$-0.80
Q3 2025
$-0.07
Q4 2025
$-0.04
Q1 2026
$-1.01
Q2 2026
Latest Revenue219.1M
Latest Net Income-58371000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.01219.1M-58371000+32.4%-352.5%
Q1 2026-$0.04207.7M-2293000+38.6%+81.0%
Q4 2025-$0.07211.6M-4105000+21.5%-125.0%
Q3 2025-$0.80192.1M-45117000+9.3%-214.3%
Q2 2025$0.40165.5M22.5M-1.7%+11.1%
Q1 2025-$0.21149.8M-11827000+4.3%
Q4 2024$0.28174.2M15.3M+6.0%+1,300.0%
Q3 2024$0.70175.7M38.5M+14.2%+341.4%
Q2 2024$0.36168.3M19.9M
Q1 2024$0.00143.6M124.0K
Q4 2023$0.02164.3M1.2M
Q3 2023-$0.29153.9M-15976000
Supernus Pharmaceuticals (SUPN) — Earnings